Rabies virus vector transgene expression level and cytotoxicity improvement induced by deletion of glycoprotein gene.
The glycoprotein (G) of rabies virus (RV) is required for binding to neuronal receptors and for viral entry. G-deleted RV vector is a powerful tool for investigating the organization and function of the neural circuits. It gives the investigator the ability to genetically target initial infection to particular neurons and to control trans-synaptic propagation. In this study we have quantitatively evaluated the effect of G gene deletion on the cytotoxicity and transgene expression level of the RV vector. We compared the characteristics of the propagation-competent RV vector (rHEP5.0-CVSG-mRFP) and the G-deleted RV vector (rHEP5.0-ΔG-mRFP), both of which are based on the attenuated HEP-Flury strain and express monomeric red fluorescent protein (mRFP) as a transgene. rHEP5.0-ΔG-mRFP showed lower cytotoxicity than rHEP5.0-CVSG-mRFP, and within 16 days of infection we found no change in the basic electrophysiological properties of neurons infected with the rHEP5.0-ΔG-mRFP. The mRFP expression level of rHEP5.0-ΔG-mRFP was much higher than that of rHEP5.0-CVSG-mRFP, and 3 days after infection the retrogradely infected neurons were clearly visualized by the expressed fluorescent protein without any staining. This may be due to the low cytotoxicity and/or the presumed change in the polymerase gene (L) expression level of the G-deleted RV vector. Although the mechanisms remains to be clarified, the results of this study indicate that deletion of the G gene greatly improves the usability of the RV vector for studying the organization and function of the neural circuits by decreasing the cytotoxicity and increasing the transgene expression level.
Division of Systems Neuroscience, Tohoku University Graduate School of Life Sciences, Sendai, Japan.
Shinya
S
Ohara
Sho
S
Sato
Kei
K
Oyama
Ken-Ichiro
K
Tsutsui
Toshio
T
Iijima
D000200:Action Potentials; D000818:Animals; D000956:Antigens, Viral / Q000235:genetics*; D002460:Cell Line; D017353:Gene Deletion; D015870:Gene Expression; D005818:Genetic Engineering; D005822:Genetic Vectors / Q000737:chemistry; D006023:Glycoproteins / Q000172:deficiency / Q000235:genetics*; D006801:Humans; D008164:Luminescent Proteins / Q000235:genetics* / Q000378:metabolism; D009474:Neurons / Q000473:pathology / Q000821:virology; D011818:Rabies / Q000821:virology*; D011820:Rabies virus / Q000235:genetics* / Q000254:growth & development / Q000472:pathogenicity*; D051381:Rats; D017208:Rats, Wistar; D019076:Transgenes; D014759:Viral Envelope Proteins / Q000172:deficiency / Q000235:genetics*; D014774:Virulence; D014779:Virus Replication; D000097573:Red Fluorescent Protein
D000956:Antigens, Viral; D006023:Glycoproteins; D008164:Luminescent Proteins; D014759:Viral Envelope Proteins; D000097573:Red Fluorescent Protein; C064951:glycoprotein G, Rabies virus